Immunity to COVID-19 Appears Feasible

Tests in macaques show robust protection against the SARS-CoV-2 virus induced by either vaccines or natural infection.

Photograph by iStock

One of the most clinically significant scientific questions about SARS CoV-2 is whether the human immune system can protect against the disease, as the result of either vaccination or the body’s response to natural infection. 

A pair of studies in macaques, which share 93 percent of their DNA with humans, suggests that exposure to the disease or administration of a vaccine can confer protective immunity. “Our findings increase optimism that the development of COVID-19 vaccines will be possible,” said professor of medicine and of immunology Dan Barouch, senior author of both Science papers. The results are being hailed by other scientists as extremely good news. 

In the study of natural infection, the researchers exposed nine macaques to SARS-CoV-2. All recovered and developed antibodies. Five weeks later, the macaques were again exposed to the virus. This time, the animals displayed rapid immunologic control of the infection, and developed no clinically observable symptoms.

In the vaccination study, Barouch and colleagues in his Beth Israel Deaconess Medical Center laboratory tested six DNA vaccines, designed to instruct the immune system to recognize the SARS-CoV-2 virus that causes COVID-19 disease. (DNA vaccines have not traditionally been viewed as optimal platforms for human vaccine development, and are just one of many approaches being pursued worldwide.) Each vaccine was slightly different: one encoded the full sequence of the spike protein that the virus uses to enter human cells; another did the same, but deleted the cytoplasmic tail; others encoded for different fragments of the spike protein.

The researchers found that all the vaccines, delivered as an initial shot followed by a booster, conferred protection, but some were more effective than others. Furthermore, they discovered that animals that developed higher numbers of antibodies after vaccination also exhibited lower levels of virus after subsequent exposure to SARS-CoV-2. This means that measuring the antibody response could provide clues to the effectiveness of vaccines during clinical testing.

Still unclear is the durability of human immunity to this coronavirus. “Further research will be needed to address the important questions about the length of protection,” said Barouch, “as well as the optimal vaccine platforms for SARS-CoV-2 vaccines for humans.” 

Read more articles by Jonathan Shaw

You might also like

Harvard Panel Debunks the Population Implosion Myth

Public health professors parse the evidence surrounding falling U.S. birth rates.

Do Mitochondria Hold the Power to Heal?

From Alzheimer’s to cancer, this tiny organelle might expand treatment options. 

Why Heat Waves Make You Miserable

Scientists are studying how much heat and humidity the human body can take.

Most popular

Shakespeare’s Greatest Rival

Without Christopher Marlowe, there might not have been a Bard.

How MAGA Went Mainstream at Harvard

Trump, TikTok, and the pandemic are reshaping Gen Z politics.

Five Questions with Peter R. Girguis

A Harvard professor of evolutionary biology on what lurks in the deep sea  

Explore More From Current Issue

John Goldberg

Harvard in the News

University layoffs, professors in court, and a new Law School dean

Book cover of "Black Moses" by Caleb Gayle with subtitle about ambition and the fight for a Black state.

Civil Rights in the American West

A new book chronicles one man’s quest for a Black state.

Illustration of college students running under a large red "MAGA" hat while others look on with some skeptisim.

How MAGA Went Mainstream at Harvard

Trump, TikTok, and the pandemic are reshaping Gen Z politics.